Annual Current Assets
$431.69 M
+$114.00 M+35.88%
31 December 2023
Summary:
Celldex Therapeutics annual total current assets is currently $431.69 million, with the most recent change of +$114.00 million (+35.88%) on 31 December 2023. During the last 3 years, it has risen by +$233.85 million (+118.20%). CLDX annual current assets is now at all-time high.CLDX Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$778.84 M
-$33.13 M-4.08%
01 September 2024
Summary:
Celldex Therapeutics quarterly total current assets is currently $778.84 million, with the most recent change of -$33.13 million (-4.08%) on 01 September 2024. Over the past year, it has increased by +$532.91 million (+216.69%). CLDX quarterly current assets is now -6.76% below its all-time high of $835.32 million, reached on 31 March 2024.CLDX Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLDX Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +35.9% | +216.7% |
| 3 y3 years | +118.2% | +82.6% |
| 5 y5 years | +335.7% | +937.0% |
CLDX Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +118.2% | -6.8% | +216.7% |
| 5 y | 5 years | at high | +547.2% | -6.8% | +1292.8% |
| alltime | all time | at high | >+9999.0% | -6.8% | >+9999.0% |
Celldex Therapeutics Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $778.84 M(-4.1%) |
| June 2024 | - | $811.98 M(-2.8%) |
| Mar 2024 | - | $835.32 M(+93.5%) |
| Dec 2023 | $33.93 M(-3.2%) | $431.69 M(+75.5%) |
| Sept 2023 | - | $245.93 M(-7.1%) |
| June 2023 | - | $264.82 M(-8.6%) |
| Mar 2023 | - | $289.60 M(-8.8%) |
| Dec 2022 | $35.04 M(+3.6%) | $317.69 M(-5.1%) |
| Sept 2022 | - | $334.60 M(-9.1%) |
| June 2022 | - | $367.98 M(-5.8%) |
| Mar 2022 | - | $390.70 M(-4.9%) |
| Dec 2021 | $33.81 M(-11.0%) | $410.84 M(-3.7%) |
| Sept 2021 | - | $426.56 M(+154.5%) |
| June 2021 | - | $167.61 M(-7.7%) |
| Mar 2021 | - | $181.50 M(-8.3%) |
| Dec 2020 | $37.99 M(-32.4%) | $197.84 M(-2.5%) |
| Sept 2020 | - | $202.93 M(-2.9%) |
| June 2020 | - | $208.99 M(+273.7%) |
| Mar 2020 | - | $55.92 M(-16.2%) |
| Dec 2019 | $56.23 M(-0.9%) | $66.70 M(-11.2%) |
| Sept 2019 | - | $75.10 M(-11.0%) |
| June 2019 | - | $84.36 M(-5.0%) |
| Mar 2019 | - | $88.85 M(-10.3%) |
| Dec 2018 | $56.73 M(-66.8%) | $99.08 M(-10.7%) |
| Sept 2018 | - | $110.97 M(-7.7%) |
| June 2018 | - | $120.28 M(-8.2%) |
| Mar 2018 | - | $130.97 M(-9.5%) |
| Dec 2017 | $170.87 M(-9.0%) | $144.76 M(-1.7%) |
| Sept 2017 | - | $147.32 M(-8.0%) |
| June 2017 | - | $160.05 M(-7.7%) |
| Mar 2017 | - | $173.46 M(-11.3%) |
| Dec 2016 | $187.79 M(+340.3%) | $195.57 M(-6.7%) |
| Sept 2016 | - | $209.71 M(-8.3%) |
| June 2016 | - | $228.78 M(-12.3%) |
| Mar 2016 | - | $260.95 M(-11.5%) |
| Dec 2015 | $42.65 M(-0.9%) | $294.94 M(-4.6%) |
| Sept 2015 | - | $309.26 M(-8.9%) |
| June 2015 | - | $339.54 M(-6.8%) |
| Mar 2015 | - | $364.13 M(+77.6%) |
| Dec 2014 | $43.03 M(+2.7%) | $204.99 M(-10.8%) |
| Sept 2014 | - | $229.82 M(-10.1%) |
| June 2014 | - | $255.60 M(-7.7%) |
| Mar 2014 | - | $276.82 M(-9.3%) |
| Dec 2013 | $41.91 M(+3.7%) | $305.19 M(+118.1%) |
| Sept 2013 | - | $139.95 M(-10.5%) |
| June 2013 | - | $156.43 M(-15.2%) |
| Mar 2013 | - | $184.45 M(+116.7%) |
| Dec 2012 | $40.43 M(-6.7%) | $85.11 M(+8.0%) |
| Sept 2012 | - | $78.81 M(-2.0%) |
| June 2012 | - | $80.40 M(-14.7%) |
| Mar 2012 | - | $94.24 M(+72.3%) |
| Dec 2011 | $43.31 M(-7.8%) | $54.68 M(-15.1%) |
| Sept 2011 | - | $64.38 M(-12.2%) |
| June 2011 | - | $73.29 M(+58.5%) |
| Mar 2011 | - | $46.23 M(-26.6%) |
| Dec 2010 | $47.00 M(-16.7%) | $62.95 M(+6.3%) |
| Sept 2010 | - | $59.20 M(-13.3%) |
| June 2010 | - | $68.25 M(-12.8%) |
| Mar 2010 | - | $78.28 M(-6.8%) |
| Dec 2009 | $56.39 M(+148.2%) | $83.98 M(+199.8%) |
| Sept 2009 | - | $28.01 M(-16.4%) |
| June 2009 | - | $33.51 M(-19.9%) |
| Mar 2009 | - | $41.84 M(-11.1%) |
| Dec 2008 | $22.72 M(+518.0%) | $47.08 M(-15.3%) |
| Sept 2008 | - | $55.56 M(-19.5%) |
| June 2008 | - | $69.03 M(+204.4%) |
| Mar 2008 | - | $22.68 M(+298.0%) |
| Dec 2007 | $3.68 M(-80.7%) | $5.70 M(-73.3%) |
| Sept 2007 | - | $21.38 M(-21.8%) |
| June 2007 | - | $27.33 M(-19.4%) |
| Mar 2007 | - | $33.92 M(-20.0%) |
| Dec 2006 | $19.08 M | $42.40 M(-12.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2006 | - | $48.16 M(-12.4%) |
| June 2006 | - | $54.99 M(-10.2%) |
| Mar 2006 | - | $61.25 M(+148.9%) |
| Dec 2005 | $11.85 M(+5.2%) | $24.60 M(-13.9%) |
| Sept 2005 | - | $28.59 M(-13.6%) |
| June 2005 | - | $33.09 M(+14.5%) |
| Mar 2005 | - | $28.89 M(-16.3%) |
| Dec 2004 | $11.26 M(+25.2%) | $34.54 M(-5.7%) |
| Sept 2004 | - | $36.61 M(-8.9%) |
| June 2004 | - | $40.20 M(-7.5%) |
| Mar 2004 | - | $43.44 M(+94.7%) |
| Dec 2003 | $9.00 M(-4.0%) | $22.31 M(-10.0%) |
| Sept 2003 | - | $24.78 M(+37.4%) |
| June 2003 | - | $18.04 M(-13.8%) |
| Mar 2003 | - | $20.92 M(-19.1%) |
| Dec 2002 | $9.37 M(-7.6%) | $25.86 M(-11.3%) |
| Sept 2002 | - | $29.14 M(-10.3%) |
| June 2002 | - | $32.48 M(-14.0%) |
| Mar 2002 | - | $37.76 M(-12.9%) |
| Dec 2001 | $10.14 M(-13.7%) | $43.34 M(+20.7%) |
| Sept 2001 | - | $35.91 M(-15.3%) |
| June 2001 | - | $42.41 M(-9.3%) |
| Mar 2001 | - | $46.77 M(-9.7%) |
| Dec 2000 | $11.76 M(+118.0%) | $51.81 M(+4.5%) |
| Sept 2000 | - | $49.57 M(+192.5%) |
| June 2000 | - | $16.95 M(-14.0%) |
| Mar 2000 | - | $19.70 M(+36.0%) |
| Dec 1999 | $5.39 M(-23.5%) | $14.49 M(-17.7%) |
| Sept 1999 | - | $17.60 M(+74.3%) |
| June 1999 | - | $10.10 M(-21.1%) |
| Mar 1999 | - | $12.80 M(-17.9%) |
| Dec 1998 | $7.05 M(+193.8%) | $15.60 M(-4.3%) |
| Sept 1998 | - | $16.30 M(+143.3%) |
| June 1998 | - | $6.70 M(-26.4%) |
| Mar 1998 | - | $9.10 M(+23.0%) |
| Dec 1997 | $2.40 M(-38.5%) | $7.40 M(-17.8%) |
| Sept 1997 | - | $9.00 M(-18.2%) |
| June 1997 | - | $11.00 M(-12.7%) |
| Mar 1997 | - | $12.60 M(-5.3%) |
| Dec 1996 | $3.90 M(-20.4%) | $13.30 M(-11.9%) |
| Sept 1996 | - | $15.10 M(+104.1%) |
| June 1996 | - | $7.40 M(-26.7%) |
| Mar 1996 | - | $10.10 M(-25.7%) |
| Dec 1995 | $4.90 M(+63.3%) | $13.60 M(+76.6%) |
| Sept 1995 | - | $7.70 M(-35.8%) |
| June 1995 | - | $12.00 M(-20.5%) |
| Mar 1995 | - | $15.10 M(-14.7%) |
| Dec 1994 | $3.00 M(-16.7%) | $17.70 M(-16.9%) |
| Sept 1994 | - | $21.30 M(-10.5%) |
| June 1994 | - | $23.80 M(-12.5%) |
| Mar 1994 | - | $27.20 M(-7.8%) |
| Dec 1993 | $3.60 M(+12.5%) | $29.50 M(+116.9%) |
| Sept 1993 | - | $13.60 M(-13.4%) |
| June 1993 | - | $15.70 M(-11.3%) |
| Mar 1993 | - | $17.70 M(-16.9%) |
| Dec 1992 | $3.20 M(+14.3%) | - |
| Oct 1992 | - | $21.30 M(-7.4%) |
| July 1992 | - | $23.00 M(-5.0%) |
| Apr 1992 | - | $24.20 M(-4.3%) |
| Apr 1992 | $2.80 M(+7.7%) | - |
| Jan 1992 | - | $25.30 M(-1.9%) |
| Oct 1991 | - | $25.80 M(-4.8%) |
| July 1991 | - | $27.10 M(+155.7%) |
| Apr 1991 | $2.60 M(-10.3%) | $10.60 M(+6.0%) |
| Jan 1991 | - | $10.00 M(-7.4%) |
| Oct 1990 | - | $10.80 M(-12.9%) |
| July 1990 | - | $12.40 M(-2.4%) |
| Apr 1990 | $2.90 M(+16.0%) | $12.70 M(+38.0%) |
| Jan 1990 | - | $9.20 M(-14.0%) |
| Apr 1989 | $2.50 M(+78.6%) | $10.70 M(-7.8%) |
| Apr 1988 | $1.40 M(+133.3%) | $11.60 M(-17.1%) |
| Apr 1987 | $600.00 K(+50.0%) | $14.00 M(+400.0%) |
| Apr 1986 | $400.00 K | $2.80 M |
FAQ
- What is Celldex Therapeutics annual total current assets?
- What is the all time high annual current assets for Celldex Therapeutics?
- What is Celldex Therapeutics annual current assets year-on-year change?
- What is Celldex Therapeutics quarterly total current assets?
- What is the all time high quarterly current assets for Celldex Therapeutics?
- What is Celldex Therapeutics quarterly current assets year-on-year change?
What is Celldex Therapeutics annual total current assets?
The current annual current assets of CLDX is $431.69 M
What is the all time high annual current assets for Celldex Therapeutics?
Celldex Therapeutics all-time high annual total current assets is $431.69 M
What is Celldex Therapeutics annual current assets year-on-year change?
Over the past year, CLDX annual total current assets has changed by +$114.00 M (+35.88%)
What is Celldex Therapeutics quarterly total current assets?
The current quarterly current assets of CLDX is $778.84 M
What is the all time high quarterly current assets for Celldex Therapeutics?
Celldex Therapeutics all-time high quarterly total current assets is $835.32 M
What is Celldex Therapeutics quarterly current assets year-on-year change?
Over the past year, CLDX quarterly total current assets has changed by +$532.91 M (+216.69%)